Cargando…
Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome
BACKGROUND: In patients with differentiated thyroid cancer (DTC), tumor burden of persistent disease (PD) is a variable that could affect therapy efficiency. Our aim was to assess its correlation with the 2015 American Thyroid Association (ATA) risk-stratification system, and its impact on response...
Autores principales: | Ciappuccini, Renaud, Heutte, Natacha, Lasne-Cardon, Audrey, Saguet-Rysanek, Virginie, Leroy, Camille, Le Hénaff, Véronique, Vaur, Dominique, Babin, Emmanuel, Bardet, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429727/ https://www.ncbi.nlm.nih.gov/pubmed/32799836 http://dx.doi.org/10.1186/s12885-020-07269-3 |
Ejemplares similares
-
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study
por: Bardet, Stéphane, et al.
Publicado: (2020) -
(18)F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study
por: Ciappuccini, Renaud, et al.
Publicado: (2021) -
Thyroid (18)F-fluorocholine uptake in patients with chronic autoimmune thyroiditis
por: Ciappuccini, Renaud, et al.
Publicado: (2022) -
Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer
por: Ciappuccini, Renaud, et al.
Publicado: (2012) -
Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2
por: Quak, Elske, et al.
Publicado: (2021)